Streptococcus pneumoniae re-emerges as a cause of community-acquired pneumonia, including frequent co-infection with SARS-CoV-2, in Germany, 2021

• Juliane Ankert,
• Stefan Hagel,
• Claudia Schwarz,
• Kaijie Pan,
• Liz Wang,
• Christof von Eiff,
• Bradford D. Gessner,
• Christian Theilacker,
• Mathias W. Pletz

Affiliations

Juliane Ankert

Institute for Infectious Diseases and Infection Control, Jena University Hospital – Friedrich Schiller University Jena, Jena, Germany

Stefan Hagel

Institute for Infectious Diseases and Infection Control, Jena University Hospital – Friedrich Schiller University Jena, Jena, Germany

Claudia Schwarz

Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, USA

Kaijie Pan

Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, USA

Liz Wang

Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, USA

Christof von Eiff

Pfizer Pharma GmbH, Berlin, Germany

Bradford D. Gessner

Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, USA

Christian Theilacker

Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, USA

Mathias W. Pletz

Institute for Infectious Diseases and Infection Control, Jena University Hospital – Friedrich Schiller University Jena, Jena, Germany